MedPath

Investigating the safety and efficacy of injection of fat tissue cells in patients with scleroderma

Phase 1
Conditions
scleroderma.
Systemic sclerosis [scleroderma]
Registration Number
IRCT20200127046282N35
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
18
Inclusion Criteria

The patient is suffering from scleroderma and has been diagnosed by a doctor.
The patient has skin involvement in the fingers or face.
The patient is in the stable phase of the disease, which is confirmed by the attending physician.
The patient has the desire to perform the mentioned procedure.

Exclusion Criteria

having infectious diseases.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath